Oaktree Acquisition Corp. III Life Sciences

Oaktree Acquisition Corp. III Life Sciences is a blank check company sponsored by Oaktree Capital Management, the Los Angeles-based global alternative investment manager with deep roots in credit and special-situations investing. The SPAC targets the life sciences sector and trades its warrants under the ticker OACCW. The company filed an 8-K with the SEC on October 25, 2024, signaling a material corporate development during its search for a combination target. The life sciences focus aligns with Oaktree's prior SPAC vehicles, continuing the sponsor's engagement with healthcare and biotechnology dealflow. Sign up at SpacDesk for the full filing history, timeline, and real-time data on Oaktree Acquisition Corp. III Life Sciences and hundreds of other active SPACs.